This document aims to develop standard definitions and terminology for key aspects of clinical safety reporting. I also provides guidance on the appropriate mechanism for handling expedited (rapid) reporting, in the investigational (i.e. pre-approval) phase.

Keywords: Clinical development, clinical safety reporting, expedited reports, adverse drug reaction (ADR)

Current effective version

How useful do you find this page?